Following the COVID-19 pandemic, mRNA-based vaccines have been shown to provide rapid and precise immune responses, however, this technology has much wider applications. Many leading pharma and ...

Kennedy Jr. is considering pulling funding for its bird flu vaccine. Is MRNA stock a sell? It's been nearly five years since Moderna (NASDAQ: MRNA) emerged as a biotech industry disruptor ...

Forbes contributors publish independent expert analyses and insights.

The Central Bank of Egypt (CBE) issued a statement on Tuesday, specifying the working hours of banks during the holy month of Ramadan, the closing time of banks for the public and the end of working ...

A combination of mRNA and a new lipid nanoparticle could help heal damaged lungs, according to new research from the Perelman School of Medicine at the University of Pennsylvania. Viruses ...

CureVac and partner GSK are, meanwhile, also developing an mRNA-based flu vaccine, but are a little further back in development, as their shot is in phase 1 testing.